Breakthroughs in Bladder Cancer Immunotherapy, with Matthew Galsky Cancer Research Institute 44:28 8 years ago 12 154 Скачать Далее
Matthew Galsky, MD, on how studies focused on genetic mutations impact prostate cancer treatment OBRoncology 1:04 3 years ago 30 Скачать Далее
Matthew Galsky on Treating Different Subsets of Bladder Cancer OncLive 1:43 7 years ago 121 Скачать Далее
Matthew Galsky, MD, shares a message for patients regarding clinical progress in bladder cancer OBRoncology 1:08 3 years ago 100 Скачать Далее
Matthew Galsky, MD, discusses the practice-changing potential of the PROfound study from ESMO 2020 OBRoncology 2:30 3 years ago 26 Скачать Далее
Dr. Matthew Galsky on a Post-Treatment Nomogram in Urothelial Cancer OncLive 1:59 11 years ago 184 Скачать Далее
Matthew Galsky, MD, considers the implications of the IMvigor130 clinical study OBRoncology 1:58 3 years ago 56 Скачать Далее
Bladder Cancer Immunotherapy: Building on a history of immune response Cancer Research Institute 26:56 1 year ago 2 471 Скачать Далее
Dr. Galsky on Targeted Therapies in Bladder Cancer Targeted Oncology 2:03 10 years ago 91 Скачать Далее
Management of Urothelial Bladder Cancer with Dr Matthew Galsky Research To Practice 56:38 4 months ago 2 Скачать Далее
Matthew Galsky, MD, on the role of PD-L1 testing in previously untreated, locally advanced or mUC OBRoncology 3:31 3 years ago 43 Скачать Далее
Matthew Galsky, MD, tells us about the Phase 3 IMvigor130 study in advanced urothelial cancer OBRoncology 1:10 4 years ago 21 Скачать Далее
Galsky: Adjuvant Chemo vs. Observation in Bladder Cancer Cancer Therapy Advisor 2:34 9 years ago 150 Скачать Далее
Dr. Galsky on Progression on Immunotherapy in Bladder Cancer OncLive 0:59 6 years ago 172 Скачать Далее
Matthew Galsky, MD, considers a new standard of maintenance with the Javelin study outcomes OBRoncology 0:42 4 years ago 16 Скачать Далее
Dr. Matthew Galsky on Fatal Adverse Events Associated With mTOR Inhibitors Targeted Oncology 2:00 11 years ago 407 Скачать Далее
